Chiron Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-415
| Closed | -$32K | – | 95 |
|
2023
Q2 | $32K | Hold |
415
| – | – | 0.01% | 122 |
|
2023
Q1 | $34.4K | Hold |
415
| – | – | 0.01% | 125 |
|
2022
Q4 | $35.6K | Buy |
+415
| New | +$35.6K | 0.01% | 122 |
|
2020
Q1 | – | Sell |
-395,799
| Closed | -$25.7M | – | 66 |
|
2019
Q4 | $25.7M | Sell |
395,799
-215,466
| -35% | -$14M | 3.63% | 6 |
|
2019
Q3 | $38.7M | Buy |
611,265
+31,300
| +5% | +$1.98M | 5.93% | 3 |
|
2019
Q2 | $39.2M | Buy |
579,965
+19,404
| +3% | +$1.31M | 8.13% | 3 |
|
2019
Q1 | $36.4M | Sell |
560,561
-111,895
| -17% | -$7.27M | 6.6% | 7 |
|
2018
Q4 | $42.1M | Sell |
672,456
-52,770
| -7% | -$3.3M | 5.3% | 3 |
|
2018
Q3 | $56M | Buy |
725,226
+196,473
| +37% | +$15.2M | 3.56% | 5 |
|
2018
Q2 | $37.5M | Buy |
528,753
+97,678
| +23% | +$6.92M | 2.59% | 20 |
|
2018
Q1 | $32.5M | Buy |
431,075
+49,840
| +13% | +$3.76M | 2.83% | 13 |
|
2017
Q4 | $27.3M | Buy |
381,235
+77,500
| +26% | +$5.55M | 3.7% | 12 |
|
2017
Q3 | $24.6M | Buy |
303,735
+37,235
| +14% | +$3.02M | 5.17% | 3 |
|
2017
Q2 | $18.9M | Buy |
266,500
+80,000
| +43% | +$5.66M | 5.6% | 5 |
|
2017
Q1 | $12.7M | Buy |
+186,500
| New | +$12.7M | 4.82% | 4 |
|